Private Capital

EQT Life Sciences

Formerly LSP

EQT Life Sciences in short

  • EUR 10m - EUR 60mInvestment range
  • 54No. of portfolio companies
  • 29Investment Advisory Professionals

One of Europe’s largest and most experienced healthcare investors

EQT Life Sciences, formerly LSP, is one of Europe’s largest and most experienced healthcare investors, targeting innovative life sciences and health care companies. With a track record going back 30 years, EQT Life Sciences has raised more than €3 billion, and invested in over 150 private companies. With a dedicated team of highly experienced investment professionals, coming from backgrounds in medicine, science, and industry, EQT Life Sciences backs the smartest inventors who have ideas that could truly make a difference for patients. The team combines deep sector knowledge, analytical skills, and investment experience to provide the added value that inventors seek.

Investing to impact patients’ lives

Nowadays, too many people suffer from diseases that are not diagnosed accurately, not treated properly, not cured satisfactorily, or not cured at all. EQT Life Sciences is passionate about transforming cutting-edge scientific innovation into impactful healthcare solutions to address these challenges. We believe that the only way to do this sustainably, is by identifying the most innovative solutions to the greatest unmet clinical needs, and to repeatedly generate superior returns for our investors. We are proud to see the results of our work improving the quality of life for patients all around the world.

Read more here

Current portfolio

CompanyDirectory
  • AM-Pharma
  • Aelin Therapeutics
  • Amolyt Pharma

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180